$3.770
+0.030 (+0.80%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Fulcrum Therapeutics Inc (FULC) Moving Averages Convergence Divergence (MACD) indicator is -0.00, suggesting FULC is Buy.
Fulcrum Therapeutics Inc (FULC) 20-Day simple moving average is 3.71, while Fulcrum Therapeutics Inc (FULC) share price is $—, making it Buy.
Fulcrum Therapeutics Inc (FULC) 60-Day simple moving average is 3.76, while Fulcrum Therapeutics Inc (FULC) share price is $—, making it Buy.
Technical Analysis for FULC
AI Technical FULCAs of 2026-11-03, the technical board for Fulcrum Therapeutics Inc (FULC) reads buy: 6 indicators are flashing buy, 4 are indicating sell, and 3 are neutral. Price at $3.77 sits below the 200-day moving averages and above the 5-day, 10-day, 20-day and 60-day.
Momentum readings: RSI stands at 55.207, MACD stands at -0.00302 (Sell), Stochastic %K stands at 54.545, Stochastic %D stands at 48.485 and CCI stands at 118.095 (Sell).
FULC trades above the 60-day SMA (3.76) and below the 200-day SMA (5.76). Immediate resistance sits at Classic R1 3.79, then R2 3.88. Support sits at Classic S1 3.63, then S2 3.55.
Fulcrum Therapeutics Inc (FULC) Support & Resistance Level
Fulcrum Therapeutics Inc (FULC) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 55.207 |
| STOCHk_14_3_3 | 54.545 |
| STOCHd_14_3_3 | 48.485 |
| CCI_20 | 118.095 |
| AO_5_34 | 0.006 |
| MOM_10 | 0.070 |
| MACD_12_26_9 | -0.003 |
Fulcrum Therapeutics Inc (FULC) Relative Strength Index (RSI_14) is 55.207, creating a Neutral signal.
Fulcrum Therapeutics Inc (FULC) Stochastic %K is 54.545, creating a Neutral signal.
Fulcrum Therapeutics Inc (FULC) Stochastic %D is 48.485, creating a Neutral signal.
Fulcrum Therapeutics Inc (FULC) CCI_20 is 118.095, creating a Sell signal.
Fulcrum Therapeutics Inc (FULC) Awesome Oscillator (AO) is 0.006, creating a Buy signal.
Fulcrum Therapeutics Inc (FULC) Momentum (MOM) is 0.070, creating a Buy signal.
Fulcrum Therapeutics Inc (FULC) Moving Average Convergence Divergence (MACD) is -0.003, creating a Sell signal.
Fulcrum Therapeutics Inc (FULC) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.728 | Buy |
| MA_10 | 3.709 | Buy |
| MA_20 | 3.708 | Buy |
| MA_60 | 3.764 | Buy |
| MA_200 | 5.764 | Sell |
| MA_250 | 6.755 | Sell |
Fulcrum Therapeutics Inc (FULC) 5-Day simple moving average is 3.728, while Fulcrum Therapeutics Inc (FULC) share price is $, making it a Buy.
Fulcrum Therapeutics Inc (FULC) 10-Day simple moving average is 3.709, while Fulcrum Therapeutics Inc (FULC) share price is $, making it a Buy.
Fulcrum Therapeutics Inc (FULC) 20-Day simple moving average is 3.708, while Fulcrum Therapeutics Inc (FULC) share price is $, making it a Buy.
Fulcrum Therapeutics Inc (FULC) 60-Day simple moving average is 3.764, while Fulcrum Therapeutics Inc (FULC) share price is $, making it a Buy.
Fulcrum Therapeutics Inc (FULC) 200-Day simple moving average is 5.764, while Fulcrum Therapeutics Inc (FULC) share price is $, making it a Sell.
Fulcrum Therapeutics Inc (FULC) 250-Day simple moving average is 6.755, while Fulcrum Therapeutics Inc (FULC) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.